Ex-Biogen Commercial Exec, Kingsley, Named Medicines Co. Prez

Xconomy New York — 

Tony Kingsley, a former top commercial executive at Biogen (NASDAQ: BIIB), has been named the president and chief operating officer of The Medicines Co. (NASDAQ: MDCO), of Parsippany, NJ. Kingsley joined Biogen in 2010 and oversaw the launch of the multiple sclerosis drug dimethyl fumarate (Tecfidera). He left the company in October.